Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Eur J Haematol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SAKAROU M, Eisele L, Duhrsen U, Huttmann A, et al
    Efficacy of the GMALL-B-ALL/NHL2002 Protocol in Burkitt Leukaemia/Lymphoma and Aggressive Non-Hodgkin-Lymphomas with or without CNS-Involvement.
    Eur J Haematol. 2018 Nov 24. doi: 10.1111/ejh.13199.
    PubMed     Text format     Abstract available


  2. YONESE I, Takase H, Yoshimori M, Onozawa E, et al
    CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
    Eur J Haematol. 2018 Nov 2. doi: 10.1111/ejh.13191.
    PubMed     Text format     Abstract available


    October 2018
  3. WOLFF T, Schulz H, Losem C, Reichert D, et al
    Prophylaxis of Chemotherapy-induced Neutropenia and Febrile Neutropenia with Lipegfilgrastim in Patients with Non-Hodgkin Lymphoma (NADIR study).
    Eur J Haematol. 2018 Oct 22. doi: 10.1111/ejh.13189.
    PubMed     Text format     Abstract available


  4. DADA R, Usman B
    Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint-inhibitors: feasibility and safety.
    Eur J Haematol. 2018 Oct 20. doi: 10.1111/ejh.13186.
    PubMed     Text format     Abstract available


    July 2018
  5. KRIEGSMANN K, Wack M, Kriegsmann M, Cremer M, et al
    Selective Contrast-enhanced Computed Tomography is Appropriate in Diffuse Large B-cell Lymphoma Therapy Response Assessment.
    Eur J Haematol. 2018 Jul 26. doi: 10.1111/ejh.13150.
    PubMed     Text format     Abstract available


  6. REPETTO-LLAMAZARES AHV, Malenge MM, O'Shea A, Eiriksdottir B, et al
    Combination of (177) Lu-lilotomab with rituximab significantly improves the therapeutic outcome in pre-clinical models of non-Hodgkin's lymphoma.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13139.
    PubMed     Text format     Abstract available


  7. SPUKTI EU, Schmidt LH, Schulze A, Schliemann C, et al
    (90) Y-ibritumomab-tiuxetan as a therapeutic alternative for Follicular lymphoma (FL): A single-center experience.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13138.
    PubMed     Text format     Abstract available


    June 2018
  8. SU YJ, Wang PN, Chang H, Shih LY, et al
    Extranodal NK/T Cell Lymphoma, Nasal Type: Clinical Features, Outcome and Prognostic Factors in 101 Cases.
    Eur J Haematol. 2018 Jun 16. doi: 10.1111/ejh.13126.
    PubMed     Text format     Abstract available


  9. ZHOU LL, Xu XY, Ni J, Zhao X, et al
    T-cell lymphomas associated gene expression signature: Bioinformatics analysis based on gene expression Omnibus.
    Eur J Haematol. 2018;100:575-583.
    PubMed     Text format     Abstract available


    May 2018
  10. NOESSLINGER T, Panny M, Simanek R, Moestl M, et al
    High dose Bendamustine-EAM followed by autologous stem cell rescue results in long term remission rates in lymphoma patients, without renal toxicty.
    Eur J Haematol. 2018 May 25. doi: 10.1111/ejh.13102.
    PubMed     Text format     Abstract available


  11. SORIGUE M, Tuset V, Sancho JM
    Treatment of localized-stage follicular lymphoma.
    Eur J Haematol. 2018 May 12. doi: 10.1111/ejh.13093.
    PubMed     Text format     Abstract available


  12. BJORKHOLM M, Weibull CE, Eloranta S, Smedby KE, et al
    Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma - a population-based study from Sweden.
    Eur J Haematol. 2018 May 4. doi: 10.1111/ejh.13090.
    PubMed     Text format     Abstract available


  13. GOLSTEIN S, Muylle K, Vercruyssen M, Spilleboudt C, et al
    Long-term follow-up of 2 patients treated with (90) Y-rituximab Radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.
    Eur J Haematol. 2018 May 2. doi: 10.1111/ejh.13087.
    PubMed     Text format     Abstract available


    April 2018
  14. MEISTER A, Hentrich M, Wyen C, Hubel K, et al
    Malignant lymphoma in the HIV-positive patient.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13082.
    PubMed     Text format     Abstract available


  15. GRIGNANO E, Laurent J, Deau B, Burroni B, et al
    The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high risk diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13080.
    PubMed     Text format     Abstract available


  16. TERZIEV D, Hutter B, Klink B, Stenzinger A, et al
    Nivolumab maintenance after salvage autologous stem cell transplantation results in long term remission in multiple relapsed primary cns lymphoma.
    Eur J Haematol. 2018 Apr 6. doi: 10.1111/ejh.13072.
    PubMed     Text format     Abstract available


    March 2018
  17. CHENG CL, Liu JH, Chou SC, Yao M, et al
    Retrospective analysis of front line treatment efficacy in elderly patients with diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Mar 30. doi: 10.1111/ejh.13069.
    PubMed     Text format     Abstract available


  18. KRIEGSMANN K, Rieger M, Schwarzbich MA, Sitter S, et al
    Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
    Eur J Haematol. 2018 Mar 25. doi: 10.1111/ejh.13064.
    PubMed     Text format     Abstract available


  19. LAKSHMAIAH KC, Asati V, Babu KG, Lokanath D, et al
    Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma.
    Eur J Haematol. 2018 Mar 22. doi: 10.1111/ejh.13068.
    PubMed     Text format     Abstract available


  20. GASCON P, Krendyukov A, Hobel N, Aapro M, et al
    MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxis.
    Eur J Haematol. 2018;100:241-246.
    PubMed     Text format     Abstract available


    February 2018
  21. BOUTSIKAS G, Terpos E, Papatheodorou A, Tsirkinidis P, et al
    Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
    Eur J Haematol. 2018;100:131-139.
    PubMed     Text format     Abstract available


    January 2018
  22. TANAKA Y, Maeshima AM, Nomoto J, Makita S, et al
    Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Eur J Haematol. 2018 Jan 28. doi: 10.1111/ejh.13033.
    PubMed     Text format     Abstract available


    December 2017
  23. JAMROZIAK K, Szymczyk A, Hus M, Wojciechowska M, et al
    Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).
    Eur J Haematol. 2017 Dec 15. doi: 10.1111/ejh.13016.
    PubMed     Text format     Abstract available


    November 2017
  24. LI JW, Li YJ, Zhong MZ, Liu XL, et al
    Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-Cell lymphoma: A multicenter retrospective study.
    Eur J Haematol. 2017 Nov 30. doi: 10.1111/ejh.13004.
    PubMed     Text format     Abstract available


  25. SCHILLER J, Klein S, Engels M, Buttner R, et al
    A Cryptosporidium infection in a patient with relapsed T lymphoblastic lymphoma undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2017 Nov 15. doi: 10.1111/ejh.12998.
    PubMed     Text format     Abstract available


    October 2017
  26. HOLLANDER P, Rostgaard K, Smedby KE, Molin D, et al
    An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
    Eur J Haematol. 2017 Oct 24. doi: 10.1111/ejh.12987.
    PubMed     Text format     Abstract available


  27. ELORANTA S, Branvall E, Celsing F, Papworth K, et al
    Increasing incidence of Primary CNS lymphoma but no improvement in survival in Sweden 2000-2013.
    Eur J Haematol. 2017 Oct 6. doi: 10.1111/ejh.12980.
    PubMed     Text format     Abstract available


    September 2017
  28. BROCKELMANN PJ, Zagadailov EA, Corman SL, Chirikov V, et al
    Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma who are Ineligible for Autologous Stem Cell Transplant: A Germany and UK Retrospective Study.
    Eur J Haematol. 2017 Sep 26. doi: 10.1111/ejh.12973.
    PubMed     Text format     Abstract available


    June 2017
  29. CAMPIONI D, Gentili V, Cavazzini F, Bortolotti D, et al
    Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome.
    Eur J Haematol. 2017;98:635-637.
    PubMed     Text format     Abstract available


    May 2017
  30. GLAVEY S, Quinn J, McCloy M, Sargent J, et al
    Emergence of Bruton's Tyrosine Kinase-negative Hodgkin Lymphoma During Ibrutinib Treatment of Chronic Lymphocytic Leukaemia.
    Eur J Haematol. 2017 May 31. doi: 10.1111/ejh.12911.
    PubMed     Text format     Abstract available


  31. KAWAMOTO K, Miyoshi H, Yanagida E, Yoshida N, et al
    Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Eur J Haematol. 2017;98:459-466.
    PubMed     Text format     Abstract available


    February 2017
  32. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: